1990
DOI: 10.1007/bf00155595
|View full text |Cite
|
Sign up to set email alerts
|

An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells

Abstract: Systemic administration of swainsonine, an indolizidine alkaloid, inhibits the experimental metastasis of B16-F10 murine melanoma cells. This activity can be attributed primarily to swainsonine-mediated enhancement of host natural killer cell activity. As one next step towards investigating the potential therapeutic utility of this drug, its efficacy in enhancing host survival in the same B16-F10 model system has been assessed. In studies employing intravenously injected tumor cells, pretreatment of mice with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

1990
1990
2008
2008

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(6 citation statements)
references
References 27 publications
0
6
0
Order By: Relevance
“…inhibitor of ␣-mannosidase II, an enzyme upstream of Mgat5 in the N-glycosylation pathway. Swainsonine has been shown to inhibit tumor growth and lung colonization in a number of animal models (42)(43)(44) and has demonstrated low toxicity as well as evidence of clinical efficacy in two phase I clinical trials (45). In addition to its direct effect on tumor cells, swainsonine enhances activation of Th cells (46), CTLs (47), NK and LAK cells (23,48), as well as macrophages (49), all of which have potential for antitumor activity.…”
Section: Discussionmentioning
confidence: 99%
“…inhibitor of ␣-mannosidase II, an enzyme upstream of Mgat5 in the N-glycosylation pathway. Swainsonine has been shown to inhibit tumor growth and lung colonization in a number of animal models (42)(43)(44) and has demonstrated low toxicity as well as evidence of clinical efficacy in two phase I clinical trials (45). In addition to its direct effect on tumor cells, swainsonine enhances activation of Th cells (46), CTLs (47), NK and LAK cells (23,48), as well as macrophages (49), all of which have potential for antitumor activity.…”
Section: Discussionmentioning
confidence: 99%
“…Thus swainsonine is a potent and specific inhibitor of amannosidase (Dorling et d., 1980) and castanospermine is an excellent inhibitor of certain aand pglucosidases (Saul et al, 1984). Both compounds exhibit potential chemotherapeutic properties, swainsonine as an antimetastatic agent (Humphries et al, 1990) and castanospermine and its derivatives as antiviral agents (Gruters et a f . , 1987;Tyms et ul., 1987;Walker et al, 1987).…”
Section: Introductionmentioning
confidence: 99%
“…More recently, a group in Perth at Murdoch University succeeded in extracting the alkaloid, swainsonine 2 from a desert shrub which causes poisoning in cattle [3]. Swainsonine has been found to exhibit an interesting spectrum of biological activity [4], especially as a potent, reversible inhibitor of various a-n-mannosidases [5].…”
Section: Prologuementioning
confidence: 99%